These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5515015)

  • 1. [Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative].
    Salmini G; Cione R; Oldrini R
    Minerva Cardioangiol; 1970 May; 18(5):311-5. PubMed ID: 5515015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A; Malagù I; Golinelli G; Soffritti A
    Minerva Med; 1970 Sep; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of tachyarrhythmia and stenocardia due mainly to neurodystonia, with a beta-blocking drug].
    Melli A; Golinelli G; Malagù I
    Minerva Med; 1969 Jan; 60(8):325-30. PubMed ID: 5766862
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
    Gill E
    Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-anginal action of a combination of a beta-blocking agent, butydrine, with a nitroderivative with prolonged action, pentaerythrite. Clinical evaluation].
    Cerri B; Bianchi G
    Clin Ter; 1969 Dec; 51(5):431-7. PubMed ID: 4392754
    [No Abstract]   [Full Text] [Related]  

  • 11. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
    Giard
    J Sci Med Lille; 1972 Nov; 90(11):407-10. PubMed ID: 4650213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative therapy of angina pectoris].
    Nager F
    Schweiz Med Wochenschr; 1970 May; 100(20):855-61. PubMed ID: 4997632
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nitro-sandolanid in angina pectoris].
    Stieglitz T
    Med Welt; 1973 Apr; 24(16):655-6. PubMed ID: 4756332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of angina pectoris with Dilcoran 80].
    Strickler W
    Landarzt; 1967 Oct; 43(30):1485-9. PubMed ID: 5609195
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

  • 18. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
    Cole RE; Goldberg RI
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.